Peter Stalmans, EURETINA 2020 – End-stage Retinitis Pigmentosa Patients Implanted with 3D–neural Interface Retinal Prosthesis
Prof. Peter Stalmans (University Hospitals, Leuven, Belgium) talked us through his presentation at EURETINA on first reported clinical results from end-stage retinitis pigmentosa patients implanted with an innovative 3D neural interface retinal prosthesis.
Questions
- Could you give us an overview of advances in retinal prosthesis approaches in the treatment of advanced retinitis pigmentosa (RP)? (00:06)
- Could you tell us a little about the 3D neural interface retinal prosthesis you have been investigating? (01:48)
- What have been the early clinical findings with this device? (03:30)
- Which patients are most likely to benefit from this approach and what further studies are planned? (04:13)
- What challenges remain to be resolved in successful restoration of vision in end-stage RP patients? (05:01)
Speaker Disclosure: Results presented are from a clinical trial sponsored by Nano-Retina.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of EURETINA 2020.
